Article
European Biosimilar Updates
On February 13, 2026, STADA and Bio-Thera announced that they have received European Marketing Authorization for GOTENFIA®, a golimumab biosimilar to Johnson & Johnson's SIMPONI®.
Goodwin Procter LLP